Clinical Spotlight: Benign Prostatic Hyperplasia

Advancements in Minimally Invasive Surgical Options for the Management of Benign Prostatic Hyperplasia

March 31, 2022

This article examines key advancements in the management of benign prostatic hyperplasia by reviewing factors to consider for early intervention, guidelines in the use of minimally invasive surgical treatments, and the importance of real-world evidence and the patient perspective.

Refining Treatment Approaches to Benign Prostatic Hyperplasia with Precision Diagnostics and Minimally Invasive Surgical Therapies

March 31, 2022

In this interview, Steven Kaplan, MD, from the Men's Wellness Program at the Icahn School of Medicine at Mount Sinai in New York discusses treatment goals, shared decision-making, and long-term implications of currently available therapies for patients with benign prostatic hyperplasia.

Treatment Decision-Making and Symptom Management for Patients With Benign Prostatic Hyperplasia

March 31, 2022

In this interview, Steven N. Gange, MD, FACS, director of education with Summit Urology Group, Granger Medical Clinic and principal investigator with JBR-Utah, discusses factors affecting treatment decision-making for patients with benign prostatic hyperplasia including patient preference, continued assessment of symptoms, and the role of minimally invasive therapies.